Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Lipid Effects of PCSK9 Monoclonal Antibodies on Vessel Wall
Sabina Ugovšek, Miran Šebeštjen
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3625-3625
Open Access | Times Cited: 13

Showing 13 citing articles:

New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
Giovanna Gallo, Carmine Savoia
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2973-2973
Open Access | Times Cited: 30
PCSK9 inhibitors for acute coronary syndrome: the era of early implementation
Hongzhen Chen, Xiaomin Chen
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice
Xueying Zhang, Qingqing Lu, Yanjie Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
Dimitris Kounatidis, Nikolaοs Tentolouris, Natalia G. Vallianou, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 388-388
Open Access | Times Cited: 3
Monoclonal antibodies for dyslipidemia in adults: a focus on vulnerable patients groups
Na‐Qiong Wu, Zhi-Fan Li, Meng-Ying Lu, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 157-169
Closed Access | Times Cited: 2
Early Use of PCSK9 Inhibitors in the Prognosis of Patients with Acute Coronary Syndrome by Protecting Vascular Endothelial Function
Linghao Xu, Yuanqi Wang, Yiqiong Wang, et al.
Pharmacology (2024), pp. 1-14
Closed Access | Times Cited: 1
The Anti-Thrombotic Effects of PCSK9 Inhibitors
Martin Jozef Péč, J Benko, Jakub Jurica, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1197-1197
Open Access | Times Cited: 4
Preclinical toxicity assessment of a peptide-based antiPCSK9 vaccine in healthy mice
Amir Abbas Momtazi‐Borojeni, Maciej Banach, Sayed Abbas Tabatabaei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114170-114170
Open Access | Times Cited: 7
Place des inhibiteurs du PCSK9 dans le traitement des hypercholestérolémies
Cécile Yelnik
La Presse Médicale Formation (2024) Vol. 5, Iss. 2, pp. 145-150
Open Access
PCSK9 inhibitors ameliorate arterial stiffness in ACS patients: evidences from mendelian randomization, cohort studies and basic experiments
Linghao Xu, Liang Wang, Yuanqi Wang, et al.
Research Square (Research Square) (2024)
Open Access
PCSK9 inhibitors ameliorate arterial stiffness in ACS patients: evidences from Mendelian randomization, a retrospective study and basic experiments
Linghao Xu, Liang Wang, Yuanqi Wang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Lipoprotein transport and metabolism markers in patients with myocardial infarction in the Biobank of Yugra blood sample collection
A. S. Vorobyov, Maxim Donnikov, Oleg S. Glotov, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 23, Iss. 11, pp. 4178-4178
Open Access
Comment on "Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis"
Levent Pay
Balkan Medical Journal (2023), pp. 83-84
Open Access
Page 1

Scroll to top